Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Invasive thymoma: a clinical study of 23 cases.

M E Froudarakis1, O Tiffet, P Fournel

  • 1Department of Pneumonology-Thoracic Oncology, University Hospital of Saint-Etienne, France. mfroud@med.uoc.gr

Respiration; International Review of Thoracic Diseases
|July 21, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exposure-response relationship of niraparib in maintenance therapy for recurrent ovarian cancer: ancillary analysis of the French GINECO-NiQoLe study.

ESMO open·2025
Same author

Real-world effectiveness and tolerability of sotorasib in patients with KRAS G12C-mutated metastatic non-small cell lung cancer: The IFCT-2102 Lung KG12Ci study.

European journal of cancer (Oxford, England : 1990)·2025
Same author

Loss of smell in lung cancer patients undergoing chemotherapy: Prevalence and relationship with food habit changes.

Lung cancer (Amsterdam, Netherlands)·2023
Same author

[Management of EGFR mutated non-small cell lung carcinoma patients].

Revue des maladies respiratoires·2022
Same author

[Congenital thoracic deformities and 3D custom-made implants. New classification based on a series of 789 treated cases].

Annales de chirurgie plastique et esthetique·2022
Same author

[Place of 3D custom-made implants after failure of modeling steno-chondro-plasties].

Annales de chirurgie plastique et esthetique·2022

Adequate surgical removal and early disease stage significantly improve survival for invasive thymoma patients. Salvage therapies offer moderate response rates for recurrent cases, impacting overall survival.

Area of Science:

  • Oncology
  • Thoracic Surgery
  • Medical Research

Background:

  • Invasive thymoma is a rare mediastinal tumor with debated clinicopathological characteristics influencing patient survival.
  • Treatment primarily involves tumor resection, with adjuvant or palliative radiation therapy (RT) and/or chemotherapy (CT) being discussed for unresectable or recurrent cases.

Purpose of the Study:

  • To assess patients with invasive thymoma, focusing on factors that predict survival.
  • To analyze the impact of diagnosis stage, histology, and treatment modalities on invasive thymoma outcomes.

Main Methods:

  • Retrospective study of 23 invasive thymoma patients.
  • Assessed parameters included age, symptoms, histology, stage, treatment, and survival.
  • Primary therapies involved tumor resection with CT/RT (11 patients) or palliative RT/CT (12 patients), with cisplatin-based CT regimens.

Related Experiment Videos

Main Results:

  • The median overall survival was 20 months, with a five-year survival rate of 43.5%.
  • Surgical resection (p < 0.0001) and diagnosis stage (p = 0.006) significantly impacted survival, while histology did not (p = 0.12).
  • Salvage treatment for relapsed patients showed a 33.3% response rate and improved survival (p = 0.019).

Conclusions:

  • Disease stage at diagnosis and adequate surgical removal are key determinants of invasive thymoma outcomes.
  • Salvage treatment for recurrent thymoma can achieve moderate response rates and enhance survival.